Los mejores proctólogos — TOP-307 médicos

Profesor especialista en cirugías laparoscópicas de intestino, tratamiento de cáncer de recto y colon, y operaciones mínimamente invasivas de ano con 15 años de experiencia. Miembro de la Sociedad Internacional de Cirujanos Universitarios de Colon y Recto, Sociedad Estadounidense de Cirujanos Abdominales, Asociación Quirúrgica Estadounidense y Sociedad Europea de Coloproctología.

El Dr. X es un cirujano altamente experimentado, actualmente se desempeña como Director del Comité de Capacitación y Educación de la Sociedad Coreana de Cirugía, Director del Comité de Tecnología de la Información de la Sociedad Coreana de Coloproctología, Director de la Junta de Asuntos Quirúrgicos de la Sociedad Coreana de Gastroenterología y el Vicepresidente de la Asociación Coreana de Cirujanos Robóticos. Ha realizado varias demostraciones y capacitaciones quirúrgicas en varios países y tiene un Ph.D. y MS en Cirugía de la Universidad de Corea y un Doctorado en Medicina de la Facultad de Medicina de la Universidad de Corea.

• Se especializa en Proctología, tratando afecciones como hemorroides, fisuras, fístulas.
• Práctica internacional en diversos campos de la medicina, potenciando la atención en Proctología.
• Las certificaciones significan experiencia avanzada en tratamientos médicos y quirúrgicos.
• Las membresías profesionales denotan el reconocimiento de las principales comunidades médicas.
• Ofrece consultas en línea para pacientes que buscan tratamientos de Proctología.

• Se especializa en el tratamiento de hemorroides, fisuras anales y cáncer colorrectal.
• Experto en procedimientos proctológicos mínimamente invasivos y endoscopias.

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

• Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
• Breast cancer
• Solid tumor diagnosis
• Digestive cancer
• Gynecological cancer
• Lung cancer
• Genitourinary cancer
• Sarcoma

Awards & Achievements

• Award from Himaya Foundations and University of Sharjah

Research & Publications

• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
• The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
• Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
• First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21